Yuan Xiong - Department of Electrical and Computer Engineering, Johns Hopkins University

基本信息

浏览量：22

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis

Man Melody Luo,Peijuan Penny Zhu,Ivo Nnane,Yuan Xiong,Giampaolo Merlini,Raymond L Comenzo,Efstathios Kastritis,Ashutosh D Wechalekar,Brendan M Weiss,NamPhuong Tran,Xiang Qin,Jessica Vermeulen,

JOURNAL OF CLINICAL PHARMACOLOGY（2022）

引用6浏览0WOS引用

Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjects

Kelong Han,Mark Baker,Mark Lovern,Prokash Paul,Yuan Xiong,Parul Patel,Katy P Moore, Ciara S Seal,Amy G Cutrell,Ronald D D'Amico,Paul D Benn,Raphael J Landovitz,

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2022）

引用14浏览0WOS引用

Population Pharmacokinetics Of Trastuzumab Deruxtecan In Patients With Her2-Positive Breast Cancer And Other Solid Tumors

Ophelia Yin,Yuan Xiong,Seiko Endo,Kazutaka Yoshihara,Tushar Garimella,Malaz AbuTarif,Russ Wada,Frank LaCreta

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 5 (2021): 1314-1325

引用21浏览0WOS引用

R And Nlmixr As A Gateway Between Statistics And Pharmacometrics

Matthew Fidler,Richard Hooijmaijers,Rik Schoemaker,Justin J Wilkins,Yuan Xiong,Wenping Wang

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY（2021）

引用4浏览0WOS引用

Y Model-Informed Drug Repurposing: A Pharmacometric Approach To Novel Pathogen Preparedness, Response And Retrospection

Michael Dodds,Yuan Xiong,Samer Mouksassi,Carl Kirkpatrick,Katrina Hui,Eileen Doyle,Kashyap Patel,Eugène Cox,David Wesche,Fran Brown,Craig R Rayner

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY（2021）

引用9浏览0WOS引用

Performance Of The Saem And Focei Algorithms In The Open-Source, Nonlinear Mixed Effect Modeling Tool Nlmixr

Rik Schoemaker,Matthew Fidler,Christian Laveille,Justin J Wilkins,Richard Hooijmaijers,Teun M Post,Mirjam N Trame,Yuan Xiong,Wenping Wang

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY（2019）

引用6浏览0WOS引用

VALIDATION OF THE PHARMACOKINETIC/PHARMACODYNAMIC MODEL USED FOR DOSE SELECTION OF ANDEXANET ALFA FOR REVERSAL OF ANTICOAGULATION

J. M. Leeds,Y. Xiong, M. Lovern,K. Der,G. Lu,J. Curnutte, M. Bronson,S. Souza,P. Yue, P. Conley

CLINICAL PHARMACOLOGY & THERAPEUTICSno. SUPnan (2019): S103-S104

引用0浏览0引用

VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING

Janet Leeds,Yuan Xiong, Mark Lovern,Kenneth Der,Jaap Mandema,Genmin Lu,John Curnutte,Truman Milling,Mark Crowther,Stuart Connolly,Patrick Yue,Pamela Conley

Critical Care Medicine（2019）

引用0浏览0引用

Ceftazidime-avibactam population pharmacokinetic modelling and pharmacodynamic target attainment across adult indications and patient subgroups

Jianguo Li,Mark Lovern,Michelle L Green, Joannellyn Chiu,Diansong Zhou,Craig Comisar,Yuan Xiong, Jeremy Hing,Merran MacPherson,James G Wright,Todd Riccobene,Timothy J Carrothers,

CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2019）

引用59浏览0WOS引用

POPULATION PHARMACOKINETIC ANALYSIS OF DS-8201A, A HER2-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH HER2-POSITIVE BREAST CANCER OR OTHER SOLID TUMORS

O. Yin,Y. Xiong, S. Endo, K. Yoshihara, M. AbuTarif,R. Wada, F. LaCreta

CLINICAL PHARMACOLOGY & THERAPEUTICSno. SUPnan (2019): S48-S48

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn